
CAS 1142363-52-7
:Fórmula:C27H35N5O2
InChI:InChI=1S/C27H35N5O2/c1-25(2)11-9-17(10-12-25)22-21(32-24(33)23-29-16-19(15-28)30-23)8-7-20(31-22)18-13-26(3,4)34-27(5,6)14-18/h7-9,16,18H,10-14H2,1-6H3,(H,29,30)(H,32,33)
Chave InChI:BNVPFDRNGHMRJS-UHFFFAOYSA-N
SMILES:CC1(CCC(=CC1)C2=C(C=CC(=N2)C3CC(OC(C3)(C)C)(C)C)NC(=O)C4=NC=C(N4)C#N)C
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Foram encontrados 6 produtos.
Edicotinib
CAS:Edicotinib (JNJ-527) is a blood-brain permeable, selective CSF-1R inhibitor, with lesser inhibitory effects on KIT and FLT3.Cost-effective and quality-assured.Fórmula:C27H35N5O2Pureza:98.58% - 99.72%Cor e Forma:SolidPeso molecular:461.65-Cyano-N-[2-(4,4-dimethylcyclohexen-1-yl)-6-(2,2,6,6-tetramethyloxan-4-yl)pyridin-3-yl]-1H-imidazole-2-carboxamide
CAS:Fórmula:C27H35N5O2Pureza:99%Cor e Forma:SolidPeso molecular:461.5991Edicotinib
CAS:5-Cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamideFórmula:C27H35N5O2Pureza:99%Peso molecular:461.6JNJ-40346527
CAS:JNJ-40346527 is an anti-inflammatory drug that belongs to the group of quinoline derivatives. It has been shown to have a tumor treatment effect in cancer cell lines and also inhibits the production of inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6). JNJ-40346527 has been shown to be effective in treating bowel disease and rheumatoid arthritis. This molecule inhibits tumor growth by stimulating the release of colony-stimulating factor, which stimulates the proliferation of blood cells. The hydroxyl group on this molecule may contribute to its activity by interacting with DNA bases.Fórmula:C27H35N5O2Pureza:Min. 95%Peso molecular:461.6 g/molRef: 3D-SVB36352
Produto descontinuado




